| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought no open-market purchases and 14 sales by 5 insiders worth about $1.0M. The 12 months before that brought no open-market purchases and 34 sales by 4 insiders worth about $2.6M.
None of the 14 sales in the last 12 months was marked as made under a Rule 10b5-1 trading plan.
No insider has bought KALV shares in the open market in the last two years. The last purchase on record was by Albert Cha on October 30, 2020.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 51.4K | $1.39M | - | |
| CFO | 18.1K | $490.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Paul K. Audhya | Chief Medical Officer | Sale+OE | 2,686 | $20.22 | $54,300.98 | -1.8% | - | - | |
| Apr 17, 2026 | Nicole Sweeny | Chief Commercial Officer | Sale+OE | 1,862 | $20.22 | $37,642.75 | -3.5% | - | - | |
| Apr 17, 2026 | Brian Piekos | Chief Financial Officer | Sale+OE | 1,862 | $20.22 | $37,642.75 | -9.3% | - | - | |
| Apr 17, 2026 | Benjamin L Palleiko46 | Chief Executive Officer | Sale+OE | 9,550 | $20.22 | $193,065.67 | -2.0% | - | - | |
| Dec 8, 2025 | Benjamin L Palleiko46 | Chief Executive Officer | Sale+OE | 7,294 | $16.51 | $120,423.94 | -1.7% | +2.6% | - | |
| Nov 24, 2025 | Nicole Sweeny | Chief Commercial Officer | Sale+OE | 3,813 | $13.45 | $51,288.66 | -8.8% | +16.5% | - | |
| Nov 24, 2025 | Christopher Yea53 | Chief Development Officer | Sale+OE | 4,331 | $13.45 | $58,256.28 | -1.9% | +16.5% | - | |
| Nov 24, 2025 | Benjamin L Palleiko46 | Chief Executive Officer | Sale+OE | 10,940 | $13.45 | $147,153.94 | -2.6% | +16.5% | - | |
| Nov 24, 2025 | Brian Piekos | Chief Financial Officer | Sale+OE | 4,471 | $13.45 | $60,139.42 | -29.8% | +16.5% | - | |
| Nov 24, 2025 | Paul K. Audhya | Chief Medical Officer | Sale+OE | 5,296 | $13.45 | $71,236.50 | -3.9% | +16.5% | - |